Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Protagonist Therapeutics Ptgx Stock Near Support Price At 103.78 Up 0.11 20260402 Lila Stock Analysis Liberty Latin America Ltd. 8.35 Usd Minor Dip Performance Review 20260403 1 Will Collegium Coll Stock Outperform Peers Price At 32.08 Down 0.71 20260406 Is Amcon Dit Stock Worth Holding Price At 90.02 Down 1.68 20260406 Should I Buy Rpc Res Stock In 2026 Price At 6.85 Up 3.47 20260413 How Amazon AMZN competitive position is evolving Investor Concern 20260507 The structural growth drivers for James Bank BOTJ 043 20260507 Who Backs Solid Biosciences SLDB Stock Modest Uptick 20260418 Relmada Therapeutics RLMD Stock Chart Relmada Therapeutics Inc posts 103 EPS miss vs estimates MKS MKSI Stock All or None Investors Pile In 20260420 Scully Royalty SRL Quarterly Preview Q4 2009 Profit Surprises FTAI Aviation FTAI Stock Why Pricing Increase Bearish Momentum 20260420 JAGX Jaguar Health posts wider than expected Q3 2025 loss and slight year over year revenue dip with shares climbing slightly today Cigna Group CI Poised for Potential Q1 Upside Following Peer UnitedHealths DoubleDigit Earnings Beat How will HarleyDavidson HOG earnings compare to expectations Q4 2025 Profit Disappoints DRDBU Roman DBDR reports silent quarter with all metrics NA as SPAC restructuring continues investors await target update The real value proposition of SiriusPoint SPNT stock Institutional Demand 20260508 Renasant Corporation RNST Stock Is It Gaining Market Strength Q1 2026 Earnings Beat Estimates What Wall Street expects from Eco Wave WAVE this quarter Eco Wave beats EPS by 193 posts narrower Q4 loss Wall Street Makes Massive Bet on BloodBased Cancer Testing Innovation WD40 Company WDFC Unchanged at 20158 RangeBound Trading 20260515 Sana Biotechnology SANA Crushes Q1 2026 Estimates EPS 017 Tops Views Musk vs Altman Trial Reveals Tensions at OpenAI Over NonProfit Mission Cisco and Qualcomm Lead Market Cap Movers in Thursday Trading Bill Ackman Builds Microsoft Stake During Q1 SellOff Betting on AI and Cloud Growth United Bankshares UBSI Surges 213 Nearing 4479 Resistance 20260518 Anthropics Mythos Triggers Urgent Cybersecurity Overhaul Across US Banking Sector Armada Raises 230 Million at 2 Billion Valuation Plans Arizona Factory with Johnson Controls KNX Q1 2026 Earnings Earnings Miss Weighs on Shares as EPS Falls Short of Estimates Scholar Rock SRRK Q1 2026 Earnings Prerevenue Biotech Misses Estimates as Clinical Pipeline Progress Remains in Focus Hasbro Beats FirstQuarter Estimates on Strong Gaming Performance SP 500 Edges Higher as Healthcare and Tech Lift Broadly Positive Session SpaceX Scrubs Starship Test Flight Plans Friday Retry After LastMinute Hold Post Office Horizon Inquiry Faces FiveYear Delay Without 193m Funding Boost Police Chief Warns Puig Shares Decline as Este Lauder Merger Talks End European Markets Edge Higher Amid Geopolitical and Economic Focus SCNX Q1 2026 Earnings Strong EPS Beat Driven by Cost Management CHRW Q1 2026 Earnings EPS Surpasses Estimates Amid Mixed Market Signals LMRI Q1 2026 Earnings EPS Surges Past Expectations by 45 Stock Edges Lower Hallador Energy Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction RAVE Q3 2024 Earnings Positive EPS Amid Limited Visibility Stock Declines AZZ Inc Nudges Higher Maintains Position Above Key Support NIQ Global Intelligence plc NIQ Shows Resilient Bounce Testing Key Resistance at 908 Atlanticus Preferred Stock ATLCP Gains 088 as Price Holds Above Key Support The one question every The LOVE investor should ask Bullish Sentiment 20260508 What Am Battery ABAT management focus reveals about priorities Investor Concern 20260507 GoHealth GOCO Stock Faces Resistance Test Smart Money Active 20260415 NBIS Nebius Group NV posts massive Q4 revenue growth and beats EPS estimates but shares edge lower today GRI Bio GRI Stock Volume Analysis Grinds Higher 20260415 Teads Holding TEAD Stock Price Channels Smart Money Active 20260415 GLUE Monte Rosa Therapeutics Inc stock rises after Q4 2025 earnings even as quarterly losses exceed analyst expectations